eFFECTOR Therapeutics, Inc.

As of March 31, 2024, eFFECTOR Therapeutics, Inc. has 3.90M shares outstanding.

As of March 31, 2024, eFFECTOR Therapeutics, Inc. maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2,448.37, indicating elevated leverage, while an interest coverage ratio of -10.94 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2024. Return on assets (ROA) is negative at -141.18, reflecting losses generated across the asset base.

As of March 31, 2024, eFFECTOR Therapeutics, Inc. has an Altman Z-Score of -13.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.